Kstation

MELSMON Inj (2mL × 50 Amps)

$410.00

Specification 2cc 50 Amp / Box

Quantity

Formulation

Key ingredients

01 Human Placenta Extract100 mg / 2 mLImprovement of menopausal disorder symptoms (MFDS indication)

Professional Injectable

MELSMON injection

2mL x 50 Ampoules

Human placenta extract injection. MFDS-approved indication: improvement of menopausal disorder symptoms

Why KSTATION

✅

100% Authentic

Genuine Korean supply

🛃

97% Clearance

Proven customs success rate

❄️

Cold-Chain

Temperature-controlled shipping

[MELSMON Product Package and Ampoule Photography]

Composition

Key Components

Human Placenta Extract

100mg per 2mL

Human placenta extract, 50 mg of water-soluble substances per mL (100 mg per 2mL ampoule), as listed in the Korean MFDS product record. Contains benzyl alcohol.

[Molecular Structure and Bioactive Components Infographic]

Indication

Approved Indication

Menopausal Symptom Improvement

Improvement of menopausal disorder symptoms, the indication listed in the Korean MFDS product record (item code 200308393).

[Before & After Results and Clinical Benefits Visualization]

Administration

Professional Usage Protocol

Pre-Treatment Assessment

Comprehensive patient evaluation and treatment area assessment by qualified healthcare professional to determine optimal injection protocol and dosage requirements.

Professional Administration

Subcutaneous injection only, using sterile technique. Avoid nerve pathways and change the injection site each time (for example, alternate left and right).

Treatment Schedule

2mL per dose, three times a week for two weeks (six injections in total), as labeled in the MFDS record.

Progress Monitoring

Regular assessment of treatment response and adjustment of protocol as needed to ensure optimal therapeutic outcomes and patient satisfaction.

[Professional Administration Technique Guide and Injection Areas]

Treatment Protocols

Recommended Applications by Target

Menopausal Support Protocol

For menopausal disorder symptoms, the approved indication in the MFDS record. Labeled course: 2mL subcutaneously, three times a week for two weeks.

[Treatment Protocol Infographic and Professional Guidelines]

Product Specifications
Specification	Details
Package Contents	50 Ampoules × 2.0 mL each
Active Ingredient	Human Placenta Extract 100mg per ampoule
Administration Route	Subcutaneous Injection only
Storage Temperature	1-30°C (Room Temperature)
Treatment Duration	2 weeks (6 injections, 3 per week)
Professional Use	Qualified Healthcare Professional Required

Important Safety Information

Professional use only. Do not use in patients with hypersensitivity to this or other drugs, suspected organic disease, severe complications of the heart, liver, kidney, or other organs, or psychogenic disorders, or in newborns and premature infants (contains benzyl alcohol). Use with caution in patients with an allergic constitution. Made from human placenta: donor screening and inactivation steps are applied, but the risk of infection transmission cannot be completely excluded. Stop use if shock, chills, nausea, fever, redness, rash, breast pain, or gynecomastia occur; pain or redness at the injection site may occur. Cut glass ampoules carefully to minimize glass fragments. Store in a sealed container at 1 to 30°C. Always administered by qualified healthcare professional.

[Product Documentation, Regulatory Compliance, and Professional Guidelines]

Frequently Asked Questions

What is MELSMON injection used for?

MELSMON injection is a human placenta extract injection. Its approved indication in the Korean MFDS product record is improvement of menopausal disorder symptoms.

What is MELSMON's active ingredient?

The active ingredient is Human Placenta Extract, 50 mg of water-soluble substances per mL (100 mg per 2mL ampoule). It contains benzyl alcohol.

How is MELSMON administered?

MELSMON is administered by subcutaneous injection only, using sterile technique. The labeled course is 2mL per dose, three times a week for two weeks (six injections total), changing the injection site each time.

Who should administer MELSMON and what are the precautions?

MELSMON is for professional use only and must be administered by a qualified healthcare professional. It must not be used in patients with hypersensitivity to this or other drugs, suspected organic disease, severe complications of the heart, liver, kidney, or other organs, or psychogenic disorders, or in newborns and premature infants (it contains benzyl alcohol). Because it is made from human placenta, the risk of infection transmission cannot be completely excluded. Injection site pain or redness may occur; stop use if shock or hypersensitivity symptoms appear.

MELSMON Excellence

MELSMON injection is a human placenta extract injection imported into Korea by Korea Melsmon Co., Ltd. Its approved indication in the MFDS product record is improvement of menopausal disorder symptoms.